Mercator Medical S.A. (MRC)
GPW
61.20
+4.30 (+7.56%)
Closed
Oct 7, 2026
Day's Range
58.8061.70
52 wk Range
37.0063.70
Financial Statements - MRC - Mercator Medical S.A.
Revenue
574.17M▲ 22.4%
Net Income
29.34M▲ 228.5%Net Margin 5.1%
EBITDA
47.32M▲ 649.0%
Free Cash Flow
-13.45M▲ 65.6%
Income Statement
| Period Ending | 2025-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 574.17M | 469.06M | 542.51M | 1.72B | 1.83B | 539.72M |
| Cost of Goods | 408.59M | 401.36M | 454.21M | 1.04B | 644.27M | 427.03M |
| Gross Profit | 165.58M | 67.70M | 88.29M | 683.80M | 1.18B | 112.68M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -13.18M | -94.41M | -73.40M | 514.88M | 1.05B | 7.40M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 28.39M | -3.79M | -186.21M | 477.22M | 1.04B | 2.06M |
| Income Tax | -946K | 19.04M | 4.57M | 32.37M | 104.99M | 4.10M |
| Net Income | 29.34M | -22.83M | -190.78M | 444.85M | 935.56M | -2.03M |
| EPS Basic | 3.1 | -2.05 | -19.41 | 44.148711 | 88.66 | -0.22 |
| EPS Diluted | 3.1 | -2.05 | -19.41 | 44.148711 | 88.33 | -0.22 |
| Basic Shares Outstanding | 9.22M | 9.58M | 9.77M | 10.12M | 10.49M | 10.58M |
| Diluted Shares Outstanding | 9.22M | 9.58M | 9.77M | 10.12M | 10.49M | 10.58M |
| Ebit | 28.87M | -2.96M | -185.88M | 477.34M | 1.04B | 9.62M |
| Ebitda | 47.32M | -8.62M | -48.26M | 556.15M | 1.06B | 27.58M |
| Net Income Continuous Operations | 29.34M | -22.83M | -190.78M | 444.85M | 935.56M | -2.03M |
| Minority Interests | -753K | 3.16M | 1.16M | 2.01M | -5.38M | -297K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
